JP2011522775A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011522775A5 JP2011522775A5 JP2010543201A JP2010543201A JP2011522775A5 JP 2011522775 A5 JP2011522775 A5 JP 2011522775A5 JP 2010543201 A JP2010543201 A JP 2010543201A JP 2010543201 A JP2010543201 A JP 2010543201A JP 2011522775 A5 JP2011522775 A5 JP 2011522775A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- pharmaceutically acceptable
- acceptable salt
- following formula
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 9
- 208000010412 Glaucoma Diseases 0.000 claims 2
- 206010030043 Ocular hypertension Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000003779 hair growth Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 230000000638 stimulation Effects 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2228208P | 2008-01-18 | 2008-01-18 | |
| US61/022,282 | 2008-01-18 | ||
| US12/352,995 | 2009-01-13 | ||
| US12/352,995 US7964595B2 (en) | 2008-01-18 | 2009-01-13 | Thiophenyl prostaglandin derivatives for treating glaucoma and ocular hypertension |
| PCT/US2009/030895 WO2009091765A1 (en) | 2008-01-18 | 2009-01-14 | Therapeutic compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011522775A JP2011522775A (ja) | 2011-08-04 |
| JP2011522775A5 true JP2011522775A5 (https=) | 2012-03-01 |
| JP5393700B2 JP5393700B2 (ja) | 2014-01-22 |
Family
ID=40876973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010543201A Expired - Fee Related JP5393700B2 (ja) | 2008-01-18 | 2009-01-14 | 治療化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7964595B2 (https=) |
| EP (1) | EP2240462B1 (https=) |
| JP (1) | JP5393700B2 (https=) |
| AU (1) | AU2009205478B2 (https=) |
| BR (1) | BRPI0906879A2 (https=) |
| CA (1) | CA2712192C (https=) |
| DK (1) | DK2240462T3 (https=) |
| ES (1) | ES2434963T3 (https=) |
| WO (1) | WO2009091765A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010027040A1 (ja) * | 2008-09-04 | 2010-03-11 | 参天製薬株式会社 | １５，１５－ジフルオロプロスタグランジンＦ2α誘導体を有効成分として含有する毛髪成長促進剤 |
| CA2874288A1 (en) * | 2012-05-30 | 2013-12-05 | Asahi Glass Company, Limited | Composition for hair growth |
| US9540357B1 (en) | 2014-07-31 | 2017-01-10 | Allergan, Inc. | 15-aryl prostaglandins as EP4 agonists, and methods of use thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4543353A (en) * | 1981-11-27 | 1985-09-24 | Farmitalia Carlo Erba S.P.A. | Ester and amide derivatives of 13,14-didehydro prostaglandins |
| JPH0692305B2 (ja) * | 1987-05-15 | 1994-11-16 | 株式会社上野製薬応用研究所 | 体温上昇剤 |
| US5688819A (en) | 1992-09-21 | 1997-11-18 | Allergan | Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| WO2000051977A1 (en) * | 1999-03-05 | 2000-09-08 | The Procter & Gamble Company | Aldehyde intermediates for the preparation of prostaglandin derivatives |
| ATE281432T1 (de) * | 1999-03-05 | 2004-11-15 | Univ Duke | C-16 ungesätigte fp-selektive prostaglandin analoge |
| IL143477A (en) | 2001-05-31 | 2009-07-20 | Finetech Pharmaceutical Ltd | Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives |
| US7166730B2 (en) * | 2000-01-27 | 2007-01-23 | Fine Tech Laboratories, Ltd | Process for the preparation of prostaglandin derivatives |
| US7101904B2 (en) * | 2004-08-10 | 2006-09-05 | Allergan, Inc. | Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US7427685B2 (en) * | 2005-12-06 | 2008-09-23 | Allergan, Inc. | Therapeutic substituted cyclopentanes |
| US20070254920A1 (en) * | 2006-04-26 | 2007-11-01 | Aerie Pharmaceuticals, Inc. | Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use |
-
2009
- 2009-01-13 US US12/352,995 patent/US7964595B2/en active Active
- 2009-01-14 DK DK09702525.8T patent/DK2240462T3/da active
- 2009-01-14 BR BRPI0906879-1A patent/BRPI0906879A2/pt not_active IP Right Cessation
- 2009-01-14 EP EP09702525.8A patent/EP2240462B1/en not_active Not-in-force
- 2009-01-14 WO PCT/US2009/030895 patent/WO2009091765A1/en not_active Ceased
- 2009-01-14 CA CA2712192A patent/CA2712192C/en not_active Expired - Fee Related
- 2009-01-14 AU AU2009205478A patent/AU2009205478B2/en not_active Ceased
- 2009-01-14 ES ES09702525T patent/ES2434963T3/es active Active
- 2009-01-14 JP JP2010543201A patent/JP5393700B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011516477A5 (https=) | ||
| JP2021063088A5 (https=) | ||
| JP2006503913A5 (https=) | ||
| JP2016528301A5 (https=) | ||
| TW200812643A (en) | Gel-type formulation for spray adherable to skin/mucosa and administration system thereof | |
| JP2012255026A5 (https=) | ||
| JP2013519645A5 (https=) | ||
| JP2013523733A5 (https=) | ||
| JP2017528503A5 (https=) | ||
| FI3504187T3 (fi) | Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten | |
| JP2016534063A5 (https=) | ||
| JP2013500977A5 (https=) | ||
| JP2020512337A5 (https=) | ||
| JP2013534527A5 (https=) | ||
| NZ603108A (en) | 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators | |
| CN102655859A (zh) | 病毒感染的组合疗法治疗 | |
| JP2019529514A5 (https=) | ||
| JP2009532373A5 (https=) | ||
| JPWO2020138491A5 (https=) | ||
| JP2012508256A5 (https=) | ||
| CA2991156A1 (en) | Compositions and methods for the treatment of viral infection | |
| JP2014515383A5 (https=) | ||
| JP2019151627A5 (https=) | ||
| JP2011522775A5 (https=) | ||
| JP2011515406A5 (https=) |